Humana (HUM) Stock Forecast & Price Target

Compare

2,500 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Moderate Buy

7 Buy

10 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$289.71

▲(21.74%Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $289.71 with a high forecast of $348.00 and a low forecast of $244.00. The average price target represents a 21.74% change from the last price of $237.98.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"229":"$229","264":"$264","299":"$299","334":"$334","369":"$369"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":348,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$348.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":289.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$289.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":244,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$244.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[229,264,299,334,369],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.58,259.92,267.26,274.6,281.94,289.28000000000003,296.62,303.96000000000004,311.3,318.64,325.98,333.32,340.65999999999997,{"y":348,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.58,255.43615384615384,258.2923076923077,261.14846153846156,264.00461538461536,266.8607692307692,269.7169230769231,272.57307692307694,275.42923076923074,278.2853846153846,281.14153846153846,283.9976923076923,286.8538461538461,{"y":289.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.58,251.92000000000002,251.26000000000002,250.60000000000002,249.94,249.28,248.62,247.96,247.3,246.64000000000001,245.98,245.32,244.66,{"y":244,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":368.58,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.26,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":349.81,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":276.54,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.08,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.95,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.19,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":268.54,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":263.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":255.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":230.54,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":252.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$348.00

Average Price Target$289.71

Lowest Price Target$244.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$267

Buy

12.19%

Upside

Reiterated

07/26/25

Humana's overall stock score reflects strong financial performance and strategic growth initiatives, bolstered by a new credit agreement enhancing financial flexibility. However, technical indicators and regulatory uncertainties pose challenges. The balanced valuation and positive earnings call sentiment further support the company's prospects, despite external risks.

Michael HaRobert W. Baird

Robert W. Baird

$300→$297

Hold

24.80%

Upside

Reiterated

07/25/25

Humana price target lowered to $297 from $300 at BairdHumana price target lowered to $297 from $300 at Baird

A.J. RiceUBS

UBS

$285

Hold

19.76%

Upside

Reiterated

07/21/25

UBS Keeps Their Hold Rating on Humana (HUM)UBS analyst AJ Rice reiterated a Neutral rating and $285.00 price target on Humana (NYSE: HUM).

Ryan LangstonTD Cowen

TD Cowen

$268

Hold

12.61%

Upside

Reiterated

07/21/25

TD Cowen Sticks to Its Hold Rating for Humana (HUM)

Erin WrightMorgan Stanley

Morgan Stanley

$290

Hold

21.86%

Upside

Reiterated

07/18/25

MA Stars loss for Humana baked into earnings bridge, says Morgan StanleyMA Stars loss for Humana baked into earnings bridge, says Morgan Stanley

John RansomRaymond James

Raymond James

$340

Buy

42.87%

Upside

Reiterated

07/18/25

Humana (HUM) Gets a Buy from Raymond James

Ann HynesMizuho Securities

Mizuho Securities

$316

Buy

32.78%

Upside

Reiterated

07/18/25

Humana loses CMS lawsuit, as expected, says MizuhoHumana loses CMS lawsuit, as expected, says Mizuho

Whit MayoLeerink Partners

Leerink Partners

$271

Hold

13.88%

Upside

Reiterated

07/18/25

Leerink Partners Sticks to Their Hold Rating for Humana (HUM)

Jason CassorlaGuggenheim

Guggenheim

$326

Buy

36.99%

Upside

Reiterated

07/18/25

Humana (HUM) Gets a Buy from Guggenheim

Stephen BaxterWells Fargo

Wells Fargo

$348

Buy

46.23%

Upside

Reiterated

07/18/25

Humana investors assumed low odds of Stars suit success, says Wells FargoHumana investors assumed low odds of Stars suit success, says Wells Fargo

Andrew Mok CFABarclays

Barclays

$500→$268

Hold

12.61%

Upside

Reiterated

07/18/25

Humana can refile Stars lawsuit at later date, says BarclaysHumana can refile Stars lawsuit at later date, says Barclays

David S MacdonaldTruist Financial

Truist Financial

$280→$260

Hold

9.25%

Upside

Reiterated

07/16/25

Humana price target lowered to $260 from $280 at TruistHumana price target lowered to $260 from $280 at Truist

Lance WilkesBernstein

Bernstein

$313→$269

Buy

13.03%

Upside

Reiterated

07/16/25

Bernstein Remains a Buy on Humana (HUM)

Ben HendrixRBC Capital

RBC Capital

$283

Buy

18.92%

Upside

Reiterated

07/14/25

RBC Capital Sticks to Their Buy Rating for Humana (HUM)

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$290

Hold

21.86%

Upside

Reiterated

06/17/25

Cantor Fitzgerald Sticks to Their Hold Rating for Humana (HUM)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$267

Buy

12.19%

Upside

Reiterated

07/26/25

Michael HaRobert W. Baird

Robert W. Baird

$300→$297

Hold

24.80%

Upside

Reiterated

07/25/25

Humana price target lowered to $297 from $300 at BairdHumana price target lowered to $297 from $300 at Baird

A.J. RiceUBS

UBS

$285

Hold

19.76%

Upside

Reiterated

07/21/25

UBS Keeps Their Hold Rating on Humana (HUM)UBS analyst AJ Rice reiterated a Neutral rating and $285.00 price target on Humana (NYSE: HUM).

Ryan LangstonTD Cowen

TD Cowen

$268

Hold

12.61%

Upside

Reiterated

07/21/25

TD Cowen Sticks to Its Hold Rating for Humana (HUM)

Erin WrightMorgan Stanley

Morgan Stanley

$290

Hold

21.86%

Upside

Reiterated

07/18/25

MA Stars loss for Humana baked into earnings bridge, says Morgan StanleyMA Stars loss for Humana baked into earnings bridge, says Morgan Stanley

John RansomRaymond James

Raymond James

$340

Buy

42.87%

Upside

Reiterated

07/18/25

Humana (HUM) Gets a Buy from Raymond James

Ann HynesMizuho Securities

Mizuho Securities

$316

Buy

32.78%

Upside

Reiterated

07/18/25

Humana loses CMS lawsuit, as expected, says MizuhoHumana loses CMS lawsuit, as expected, says Mizuho

Whit MayoLeerink Partners

Leerink Partners

$271

Hold

13.88%

Upside

Reiterated

07/18/25

Leerink Partners Sticks to Their Hold Rating for Humana (HUM)

Jason CassorlaGuggenheim

Guggenheim

$326

Buy

36.99%

Upside

Reiterated

07/18/25

Humana (HUM) Gets a Buy from Guggenheim

Stephen BaxterWells Fargo

Wells Fargo

$348

Buy

46.23%

Upside

Reiterated

07/18/25

Humana investors assumed low odds of Stars suit success, says Wells FargoHumana investors assumed low odds of Stars suit success, says Wells Fargo

Andrew Mok CFABarclays

Barclays

$500→$268

Hold

12.61%

Upside

Reiterated

07/18/25

Humana can refile Stars lawsuit at later date, says BarclaysHumana can refile Stars lawsuit at later date, says Barclays

David S MacdonaldTruist Financial

Truist Financial

$280→$260

Hold

9.25%

Upside

Reiterated

07/16/25

Humana price target lowered to $260 from $280 at TruistHumana price target lowered to $260 from $280 at Truist

Lance WilkesBernstein

Bernstein

$313→$269

Buy

13.03%

Upside

Reiterated

07/16/25

Bernstein Remains a Buy on Humana (HUM)

Ben HendrixRBC Capital

RBC Capital

$283

Buy

18.92%

Upside

Reiterated

07/14/25

RBC Capital Sticks to Their Buy Rating for Humana (HUM)

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$290

Hold

21.86%

Upside

Reiterated

06/17/25

Cantor Fitzgerald Sticks to Their Hold Rating for Humana (HUM)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

1 Month

xxx

Success Rate

23/37 ratings generated profit

Average Return

+0.90%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 62.16% of your transactions generating a profit, with an average return of +0.90% per trade.

3 Months

xxx

Success Rate

25/37 ratings generated profit

Average Return

+2.04%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 67.57% of your transactions generating a profit, with an average return of +2.04% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

21/37 ratings generated profit

Average Return

+3.54%

reiterated a buy rating 3 months ago

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 56.76% of your transactions generating a profit, with an average return of +3.54% per trade.

2 Years

xxx

Success Rate

26/37 ratings generated profit

Average Return

+9.50%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 70.27% of your transactions generating a profit, with an average return of +9.50% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 24 Buy Ratings, 27 Hold Ratings, and 0 Sell Ratings. HUM average Analyst price target in the past 3 months is 289.71.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is $5.92 with a range of $5.65 to $8.28. The previous quarter’s EPS was $11.58. HUM beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.65% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $31.87B with a range of $31.53B to $32.35B. The previous quarter’s sales results were $32.11B. HUM beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 53.04% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana Inc’s 12-month average price target is 289.71.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana Inc has 21.74% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana Inc has a consensus rating of Moderate Buy which is based on 7 buy ratings, 10 hold ratings and 0 sell ratings.

What is Humana Inc’s price target?

The average price target for Humana Inc is 289.71. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $348.00 ,the lowest forecast is $244.00. The average price target represents 21.74% Increase from the current price of $237.98.

What do analysts say about Humana Inc?

Humana Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts